A phase II study of prolonged daily temozolomide for low-grade glioma.
Phase of Trial: Phase II
Latest Information Update: 03 Nov 2009
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 03 Nov 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 03 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jan 2008 The expected completion date for this trial is now 1 Dec 2009.